ClinicalTrials.Veeva

Menu

Eating Disorders in Type 1 Insulin-dependent Diabetes Patients (Diaboulimia)

I

ICADOM Medical Center

Status

Completed

Conditions

Type 1 Diabetes
Eating Disorders

Treatments

Other: cohort

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04506216
2020-A00147-32

Details and patient eligibility

About

The purpose of this study is to determine the prevalence of eating disorders in type 1 insulin-dependent diabetes patients

Full description

The risk of developing an eating disorder is increased in type 1 diabetes patients and associated with a poor prognosis in terms of glycemic control, metabolic complications, degenerative complications, and mortality.

Therefore the terminology diaboulimia has emerged to characterize an eating disorder specific to type 1 insulin-dependent diabetes patients, with insulin under dosage with a view of losing or controlling weight and that can contribute to a deterioration of the body composition.

The purpose of this study is to determine the prevalence of eating disorders in an adult cohort with type 1 insulin-dependent diabetes.

Enrollment

200 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult patient over 18 years of age with type 1 diabetes treated with a subcutaneous insulin pump
  • Patient followed up for a subcutaneous insulin pump treatment by the healthcare provider, participating in the study (Agir à Dom group).
  • Beneficiary of social security coverage.

Exclusion criteria

  • Patient with type 2 diabetes or MODY diabetes
  • Patient wearing a pacemaker
  • Breastfeeding or pregnant woman
  • Deprived of liberty by judicial or administrative decision
  • Legal guardianship

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

200 participants in 1 patient group

cohort
Experimental group
Description:
adult patients with type 1 diabetes and insulin pump treatment . Duration of participation: 30 minutes
Treatment:
Other: cohort

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems